Changes in survival in head and neck cancers in the late 20th and early 21st century: A period analysis

Oncologist

Volumn 15, Issue 9, 2010, Pages 994-1001

  Pulte, Dianne ^a   Brenner, Hermann ^b  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

Epidemiology; Head and neck cancer; Period analysis; Population analysis; Survival

Indexed keywords

ADOLESCENT; ADULT; ADVANCED CANCER; AGE DISTRIBUTION; AGED; AGING; ARTICLE; CANCER STAGING; CANCER SURVIVAL; FEMALE; HEAD AND NECK CANCER; HUMAN; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; NASOPHARYNX CANCER; OVERALL SURVIVAL; PERIOD ANALYSIS; PRIORITY JOURNAL; STATISTICAL ANALYSIS; SURVIVAL RATE; SURVIVAL TIME; TONGUE CARCINOMA; TONSIL CARCINOMA;

AGED; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; PAPILLOMAVIRIDAE; SEER PROGRAM; SURVIVAL RATE; TIME FACTORS;

EID: 77957801207     PISSN: 10837159     EISSN: 1549490X     Source Type: Journal    
DOI: 10.1634/theoncologist.2009-0289     Document Type: Article

References (20)

1. Jemal A, Siegel R, Ward E et al. Cancer statistics, 2009. CA Cancer J Clin 2009;59:225-249.
2. Surveillance, Epidemiology, and End Results (SEER) Program Limited Use Data (1973-2006), released April, 2009 based on November 2008 submission. Bethesda, MD: National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, 2009. Available at http://seer.cancer.gov/data, accessed April 1, 2010.
3. Calais G, Alfonsi M, Bardet E et al. Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advancedstage oropharynx cancer. J Natl Cancer Inst 1999;91:2081-2086.
4. Budach W, Hehr T, Budach V et al. A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck. BMC Cancer 2006;6:28.
5. Brenner H, Gefeller O. An alternative approach to monitoring cancer patient survival. Cancer 1996;78:2004-2010.
6. Brenner H, Hakulinen T. Up-to-date long-term survival curves of patients with cancer by period analysis. J Clin Oncol 2002;20:826-832.
7. Brenner H, Söderman B, Hakulinen T. Use of period analysis for providing more up-to-date estimates of long-term survival rates: Empirical evaluation among 370,000 cancer patients in Finland. Int J Epidemiol 2002;31:456-462.
8. Brenner H, Hakulinen T. Up-to-date and precise estimates of cancer patient survival: Model-based period analysis. Am J Epidemiol 2006;164:689-696.
9. Ederer F, Axtell LM, Cutler SJ. The relative survival rate: A statistical methodology. Natl Cancer Inst Monogr 1961;6:101-121.
10. Henson DE, Ries LA. The relative survival rate. Cancer 1995;76:1687-1688.
11. Ederer F, Heise H. Instructions to IBM 650 Programmers in Processing Survival Computations. Methodological Note No. 10. Bethesda, MD: National Cancer Institute, 1959.
12. Arias E. United States Life Tables, 2000, Volume 51. National Vital Statistics Report. Hyattsville, MD: Division of Vital Statistics, Department of Health and Human Services, National Center for Health Statistics, 2002:1-39.
13. Carvalho AL, Nishimoto IN, Califano JA et al. Trends in incidence and prognosis for head and neck cancer in the United States: A site-specific analysis of the SEER database. Int J Cancer 2005;114:806-816.
14. Gupta S, Kong W, Peng Y et al. Temporal trends in the incidence and survival of cancers of the upper aerodigstive tract in Ontario and the United States. Int J Cancer 2009;125:2159-2165.
15. Hammarstedt L, Lindquist D, Dahlstrand H et al. Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer. Int J Cancer 2006;119:2620-2623.
16. Gillison ML. Human papillomavirus-related diseases: Oropharynx cancers and potential implications for adolescent HPV vaccination. J Adolesc Health 2008;43(4 suppl:S52-S60.
17. Adelstein DJ, Lavertu P, Saxton JP et al. Mature results of a phase III randomized trial comparing concurrent chemoradiotherapy with radiation therapy alone in patients with stage III and IV squamous cell carcinoma of the head and neck. Cancer 2000;88:876-883.
18. Al-Sarraf M, LeBlanc M, Giri PG et al. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase II randomized intergroup study 0099. J Clin Oncol 1998;16:1310-1317.
19. Adelstein DJ, Saxton JP, Lavertu P et al. A phase III randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer: Preliminary results. Head Neck 1997;19:567-575.
20. Pignon JP, Bourhis J, Comenge C et al. Chemotherapy added to locoregional treatment for head and neck squamous cell carcinoma: Three metaanalyses of updated individual data. Lancet 2000;355:949-955.